From #mpox to #H5N1, disease surveillance is crucial for containment. CEPI's latest blog explores how robust global disease surveillance could help the world detect future pandemic threats faster, featuring expert insight from Chikwe Ihekweazu & Jean Kaseya ⬇️cepi.net/quest-detect-n…

**SAVE THE DATE** Join us on Sept 11 for our next webinar on targeted next generation sequencing for communities & civil society. This is a great opportunity to learn & discuss about this exciting new technology! This webinar is hosted by Stop TB and FIND in collaboration ..

New technologies have driven tremendous progress in #GlobalHealth, but major gaps remain in our arsenal of tools needed to bring an end to the world’s most devastating diseases. 🔬💉💊Learn more in our fact sheet series ⬇️#Innovate4Health

IVCC has partnered with V.K.A Polymers to explore the potential of repurposing two promising insecticides for insecticide-treated nets (ITNs). If successful, these could become crucial tools in the fight to eliminate malaria. 🦟 #Malaria #Innovation ow.ly/oe2F50T8MiV

What's new in #GlobalHealth R&D? 🧪#Mpox tests 🧬Speedier #mRNA vaccines 💉Underway #Lassa vaccine trial

On Thursday, World Health Organization (WHO) asked manufacturers to submit #mpox diagnostic tests for emergency review in an effort to speed up and broaden access to effective testing amid the mpox emergency on the African continent.

Advances in #GlobalHealth innovation didn’t happen overnight. They started with strategic investments, dedication, and a vision for what’s possible. #Innovate4Health #HealthForAll

Did you know? The economic impact of antimicrobial resistance could exceed $1 trillion globally every year by the end of this decade. We can't afford to wait—action is needed now. Find out more: harvardpublichealth.org/global-health/… #AMR #HealthEconomics #DYK #DidYouKnow

📣 Save the date 📣 The 2024 Global Health Landscape Symposium (GHLS) will take place on November 18-21. We hope you'll join us at #GHLS24 as we assess the impact of this watershed year on #GlobalHealth investments and policies. 🌍 Learn more: ow.ly/A5UV50TfZ4t

🎥 "How to end malaria once and for all." Watch this insightful #TEDTalk by our long-term collaborator, Diabaté Abdoulaye of IRSS in Burkina Faso. 🌍🦟 #Malaria #EndMalaria ow.ly/OyBS50T8N92

Mark your calendar today! Join us for our upcoming webinar to mark World Sepsis Day: “Babies and bugs: innovations to address neonatal sepsis and AMR” 📆 10th September 🕐3pm EAT|1pm BST|8am EST Learn more: newborntoolkit.org/events/africas…

Vaccine safety and efficacy hinge on their ability to remain stable, from manufacturing right up to administration 💉 Learn more about 'stability preparedness' and its role in achieving the #100DaysMission in CEPI's latest publication ⬇️ mdpi.com/2076-393X/12/9…

New paper alert! Learn how experts plan on introducing innovative #AMR treatments like #zoliflodacin, if approved, to help tackle the global rise of #gonorrhoea Read: shorturl.at/HEARo

.CEPI will provide $2.05m to South African biotech company Afrigen Biologics for a proof-of-concept project to investigate whether synthetic DNA could serve as an alternative to the traditional plasmid DNA used for mRNA vaccine development, cutting timelines and costs.

Locally led development requires reimagining the role of INGOs and the systems that shape them. This webinar highlights 4 orgs—PATH, @unitaid, JSI | Better health outcomes. For all., & Stopping As Success—working to shift power & center equity in programming. 🗓️ Sept 17, 2pm UTC 🔗 bit.ly/3T6mFMs

Join us for our next #REVIVE webinar! Alan Hennessy, Mo Yin and Herbert Wetli will give an introduction to #antibiotic research and development 🔬 📅 19 September, 10 - 11.30am CEST 🔗Free registration: attendee.gotowebinar.com/register/56386…

❗Request for proposals We are seeking a #consultant to help build a sustainable market for a new rapid diagnostic test for #schistosomiasis. This tool will improve early detection and support #GlobalHealth initiatives, especially in LMICs. More details: finddx.org/wp-content/upl…

Last week, IAVI announced that the first participants at trial sites in Ghana, Liberia, and Nigeria had been vaccinated in a clinical trial of IAVI’s #Lassa fever candidate.

We are so excited to welcome our newest Advocate Member, the North Carolina Global Health Alliance (North Carolina Global Health Alliance)! The alliance is dedicated to advancing North Carolina as a center of global health, working to foster collaboration and innovation in the state and region.

Learn more about the journey of a #GlobalHealth technology from bench 🔬to bedside 👩🏾‍⚕️ 💊 in our interactive infographic.